Job Overview
Job description
- Salary:
- USD 101,000 - 301,000 per year
- Location:
- New York HQ, United States
- Work arrangement:
- On-site
General Application at ataraxis-ai in New York HQ, United States.
Requirements
WHO WE'RE LOOKING FOR
We are looking for people at any stage of their career who:
- Want to build a generational company with us, and want their work at Ataraxis to become a career-defining (or even life-defining) event.
- Are humble yet ambitious and confident. There is no work that's below you.
- Are self-motivated and relentless. You will have a lot of independence and freedom to act, and you are expected to capitalize on it.
- Have elite standards and consistently produce work at a level that sets the bar for others.
About the Company
ABOUT ATARAXIS AI
Ataraxis is a clinical AI research lab working at the intersection of multi-modal AI and precision medicine. Our goal is to make disease predictable. To accomplish this, we develop new AI methods that predict patient outcomes and treatment response, and build clinical tools to assist physicians in selecting the most optimal treatments for their patients.
Our AI research lab discovers and develops methods to recognize patterns and predict outcomes across complex, multi-modal clinical data. This spans our causality https://www.ataraxis.ai/research-causality (Ataraxis™ Tau), foundation model https://www.ataraxis.ai/research---representation-learning (Falcon and Kestrel for digital pathology), and survival analysis https://www.ataraxis.ai/research-survival-analysis research.
Our first clinical products, such as Ataraxis™ Breast https://www.ataraxis.ai/ataraxis-breast-overview for breast cancer, already help patients get the most appropriate treatment across the best academic institutions and community clinics worldwide.
At Ataraxis, you will have a unique opportunity to shape not only the future of our company, but also the future of healthcare. You will join an exceptional team at the forefront of clinical AI research and deployment. Our advisors include AI pioneers such as our founding advisor, Yann LeCun, and distinguished oncologists from top cancer research institutions, all united by the mission to redefine precision medicine.
Ataraxis has raised over $24 million in funding, including a $20 million Series A led by top venture capital funds such as Thiel Capital/Founders Fund (OpenAI, SpaceX, Palantir), Obvious Ventures (AMI Labs, Inceptive, Radical Numerics, Recursion), and AIX Ventures (Hugging Face, Perplexity).
We are an company with a flat organizational structure, where every team member is empowered to actively contribute. Leadership roles are earned by those who demonstrate initiative and consistently deliver exceptional results. Strong work ethic and the ability to prioritize ruthlessly are essential.
Additional Information
Please note that this general application is not monitored on a daily basis and you will hear from us only if there is a relevant opening that you might be a fit for, or if you have a very interesting background. We are always looking for talented people across all domain who want to contribute to our mission.
- Role:
- General Application
- Job Type:
- FullTime
Company profile
ataraxis-ai
ataraxis.aiAtaraxis AI (ataraxis-ai) is a precision oncology company that develops AI-based prognostic and predictive tests for cancer care. Its flagship platform, Ataraxis Breast, uses AI to predict recurrence risk, chemotherapy benefit and neoadjuvant treatment response across all breast cancer subtypes. The team of AI and precision oncology experts builds new methods that predict patient outcomes from multi-modal clinical data, along with tools that help physicians select treatments.
- Headquarters
- New York City, New York, United States
- Founded
- 2022
- Founders
- Jan Witowski, Krzysztof Geras
In the news
New AI Models Predict Treatment Response and Patient Outcomes – Ataraxis AI
Oncodaily - Oncology News, Insights, Stories ·